RHT.AX ASX
Resonance Health Limited
1W: +7.6%
1M: +22.4%
3M: +51.1%
YTD: +61.4%
1Y: +97.2%
3Y: +9.2%
5Y: -29.0%
A$0.07 ($0.05)
+0.00 (+5.63%)
Weekly Expected Move ±8.3%
A$0
A$0
A$0
A$0
A$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$16M
+42.3% ▲
5Y CAGR: +33.0%
Gross Profit
$15M
+33.6% ▲
5Y CAGR: +31.4%
Operating Income
$2M
+179.4% ▲
5Y CAGR: +52.1%
Net Income
$2M
+187.3% ▲
5Y CAGR: +20.9%
EPS (Diluted)
$0.00
+181.6% ▲
5Y CAGR: +19.0%
EBITDA
$2M
+276.4% ▲
5Y CAGR: +28.6%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $4M | $4M | $9M | $11M | $16M |
| YoY Growth | +1.3% | +15.0% | +95.0% | +28.9% | +42.3% |
| Cost of Revenue | $0 | $0 | $0 | $965K | $954K |
| Gross Profit | $4M | $4M | $9M | $11M | $15M |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 93.9% |
| R&D Expenses | $716K | $708K | $836K | $961K | $434K |
| SG&A Expenses | $4M | $4M | $7M | $10M | $13M |
| Operating Expenses | $6M | $6M | $8M | $11M | $13M |
| Operating Income | -$2M | -$2M | -$879K | -$2M | $2M |
| Operating Margin | -46.3% | -36.9% | -10.2% | -17.4% | 9.7% |
| Interest Expense | $0 | $0 | $0 | $319K | $339K |
| Income Before Tax | -$2M | -$1M | -$627K | -$2M | $1M |
| Tax Expense | -$410K | -$484K | -$796K | $466K | -$414K |
| Net Income | -$1M | -$780K | $169K | -$2M | $2M |
| Net Margin | -29.8% | -17.7% | 2.0% | -15.7% | 9.6% |
| EPS (Diluted) | $-0.00 | $-0.00 | $0.00 | $-0.00 | $0.00 |
| EBITDA | -$1M | -$828K | -$382K | -$1M | $2M |
| Shares Outstanding | 461M | 461M | 456M | 455M | 484M |